Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuromodulation
MedTech
Mainstay Medical merits $125M for back pain neuromod implant
Fresh off earning an updated FDA nod for its neurostim device, Mainstay Medical has closed an equity financing round to expand its global presence.
Andrea Park
Feb 28, 2024 12:07pm
FDA expands OK for Boston Sci WaveWriter spinal cord stimulators
Feb 6, 2024 12:28pm
Cognito opens biomarker study of neuromod device in Alzheimer’s
Jan 23, 2024 10:45am
JPM24: Boston Scientific drops $3.7B on neuromod player Axonics
Jan 8, 2024 10:12am
Cognito study shows white matter growth after neuromod treatment
Dec 12, 2023 10:44am
Medtronic nets EU nod for rechargeable deep-brain stimulation
Dec 6, 2023 11:32am